Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Relay Therapeutics, Inc. RLAY |
BLACKROCK INC BLK |
10,308,012 6.100% |
-4,366,250 (-29.75%) |
Filing History |
| 2025-03-20 6:13 pm Purchase |
2025-03-14 | 13G | Relay Therapeutics, Inc. RLAY |
Point72 Asset Management, L.P. | 9,694,217 5.700% |
9,694,217 (New Position) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BLACKROCK INC BLK |
14,674,262 8.800% |
5,100,839 (+53.28%) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Relay Therapeutics, Inc. RLAY |
PRICE T ROWE ASSOCIATES INC | 5,280,291 3.300% |
-3,309,134 (-38.53%) |
Filing History |
| 2024-02-14 4:20 pm Purchase |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
Casdin Capital, LLC | 7,387,943 5.990% |
1,089,369 (+17.30%) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
PRICE T ROWE ASSOCIATES INC | 8,589,425 7.000% |
8,589,425 (New Position) |
Filing History |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Relay Therapeutics, Inc. RLAY |
The Vanguard Group | 10,650,387 8.640% |
266,169 (+2.56%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BLACKROCK INC BLK |
9,573,423 7.800% |
1,575,438 (+19.70%) |
Filing History |
| 2024-01-23 09:35 am Sale |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
STATE STREET CORP STT |
4,903,578 3.980% |
-1,360,919 (-21.72%) |
Filing History |
| 2023-10-02 4:14 pm Purchase |
2023-09-21 | 13G | Relay Therapeutics, Inc. RLAY |
Casdin Capital, LLC | 6,298,574 5.160% |
6,298,574 (New Position) |
Filing History |
| 2023-07-10 10:20 am Sale |
2023-07-07 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 2,956,221 2.430% |
-6,777,627 (-69.63%) |
Filing History |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 9,733,848 8.051% |
-2,224,364 (-18.60%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Relay Therapeutics, Inc. RLAY |
The Vanguard Group | 10,384,218 8.590% |
4,185,776 (+67.53%) |
Filing History |
| 2023-02-03 3:11 pm Purchase |
2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
STATE STREET CORP STT |
6,264,497 5.180% |
6,264,497 (New Position) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BLACKROCK INC BLK |
7,997,985 6.600% |
2,004,372 (+33.44%) |
Filing History |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 11,958,212 9.947% |
-4,248,389 (-26.21%) |
Filing History |
| 2022-02-14 4:52 pm Sale |
2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
Third Rock Ventures III L.P. | 362,619 0.300% |
-10,188,496 (-96.56%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
The Vanguard Group | 6,198,442 5.740% |
6,198,442 (New Position) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 16,206,601 14.999% |
5,844,601 (+56.40%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BLACKROCK INC BLK |
5,993,613 5.500% |
5,993,613 (New Position) |
Filing History |